Enjoying this blog? Check out the rest of the Health & Wellness Channel 
According to a study that appeared online in the January 22 issue of Lancet Oncology, patients taking Nexavar® (sorafenib) need to be carefully monitored and treated.
In clinical testing, Nexavar improved overall survival by 44 percent among people with HCC. Median overall survival was 10.7 months among those treated with the drug, versus 7.9 months among […]
Cancer therapies, healing, and society.
Written by Gloria Gamat [email] for b5media.
A Dozen Steps
A Hearty Life
Alzheimer's Notes
Autism Vox
Breaking the Mirror
Breastfeeding 1-2-3
Diabetes Notes
Eating Fabulous
Genetics & Health
Grounded Fitness
Health and Men
Healthbolt
Help My Hurt
Kids Health Notes
Lively Women
Mental Health Notes
Pink Ribbon Review
Veggie Chic
Weighting Line
Womb Within
Recent Comments